Patents by Inventor Luoting Yu

Luoting Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10160771
    Abstract: A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: December 25, 2018
    Assignees: CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD., SICHUAN UNIVERSITY
    Inventors: Yang Zhang, Chunli Shen, Jian Li, Shuhui Chen, Guoping Hu, Yuquan Wei, Luoting Yu, Xin Tao
  • Patent number: 10100027
    Abstract: Provided is a benzofuran analog having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analog. The benzofuran analog has anti-hepatitis C virus activity.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: October 16, 2018
    Assignees: CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD., SICHUAN UNIVERSITY
    Inventors: Yang Zhang, Zhifei Fu, Jianfei Wang, Jian Li, Shuhui Chen, Yuquan Wei, Luoting Yu, Xin Tao
  • Publication number: 20170253614
    Abstract: A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.
    Type: Application
    Filed: February 6, 2015
    Publication date: September 7, 2017
    Inventors: Yang ZHANG, Chunli SHEN, Jian LI, Shuhui CHEN, Guoping HU, Yuquan WEI, Luoting YU, Xin TAO
  • Publication number: 20170240519
    Abstract: Provided is a benzofuran analogue having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analogue. The benzofuran analogue has anti-hepatitis C virus activity.
    Type: Application
    Filed: September 23, 2015
    Publication date: August 24, 2017
    Inventors: Yang ZHANG, Zhifei FU, Jianfei WANG, Jian LI, Shuhui CHEN, Yuquan WEI, Luoting YU, Xin TAO
  • Publication number: 20140303152
    Abstract: Benzothiazinethione derivatives of formula (I), their preparative methods and uses are provided. Benzothiazinethione derivatives of the invention have significant effect of inhibiting Mycobacterium tuberculosis.
    Type: Application
    Filed: June 15, 2011
    Publication date: October 9, 2014
    Applicant: SICHUAN UNIVERSITY
    Inventors: Luoting Yu, Yuquan Wei